Novartis Ag (NVSEF) Cash from Investing Activities Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) Cash from Investing Activities Growth (5y) (2014 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -29.80%
Jun 30, 2025 -39.47%
Dec 31, 2024 -66.90%
Jun 30, 2024 -77.09%
Dec 31, 2023 80.90%
Jun 30, 2023 -17.16%
Dec 31, 2022 -18.15%
Jun 30, 2022 -108.23%
Dec 31, 2021 24.92%
Sep 30, 2021 -12.43%
Jun 30, 2021 16.71%
Mar 31, 2021 27.67%
Dec 31, 2019 1,266.51%
Jun 30, 2019 1,117.67%
Dec 31, 2018 2,358.53%
Sep 30, 2018 -1,462.37%
Jun 30, 2018 2,284.16%
Dec 31, 2014 28.44%
Sep 30, 2014 15.61%
Jun 30, 2014 22.23%